Partnering, Strategy & Investment for Life Science Executive Leaders
LSX was born with the simple mission to connect life science executives with the partners they need to flourish. Events now take place in London, Boston and Copenhagen.
The 9th LSX World Congress is the leading partnering, strategy and investment event in Europe, with qualified 1:1 partnering at its core. The event brings together the CEOs and senior decision makers from the world’s most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practice, forge partnerships and investments – all geared at putting capital and ideas to work to help create the world’s future medicines and improve patient outcomes.
From therapeutics to techbio, devices to digital health, deep tech to platform tech and diagnostics to delivery tools, it represents the breadth, depth and convergence of the cutting-edge research and technology driving advances in the healthcare industry right now, and in the future.
En savoir plus sur l’évènement
Adhérents de Lyonbiopôle, bénéficiez d’un discount de 15% lors de votre inscription.
Pour cela, merci de contacter Olivier Szymkowiak – olivier.szymkowiak@lyonbiopole.com